| 常用名 | 瑞卡西单抗 | CAS号 | 2361290-85-7 |
|---|---|---|---|
| 价格 | ¥需询单/1mg | 纯度 | 95.0% |
| 备货期 | 需询单 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Recaticimab (SHR-1209) is a humanized monoclonal antibody that inhibits PCSK9. Receticimab mediates the degradation of PCSK9 by binding to PCSK9, increasing the level of low-density lipoprotein (LDL) receptors on the surface of hepatocytes, reducing the level of LDL in plasma, and achieving the goal of lowering blood lipids. Recaticimab has potential application in hypercholesterolemia[1][2]. 物理化学性质: CAS号:2361290-85-7 常用中文名:瑞卡西单抗 常用英文名:Recaticimab 分子式: 分子量: 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |